Certolizumab treatment of localized pyoderma gangrenosum in a pregnant patient

Different molecular pathways are disrupted in Pyoderma gangrenosum patients and are associated with the severity of the disease

(2023) Ronald Rodrigues Moura et al.   Scientific Reports

Pyoderma gangrenosum following anti-TNF therapy in chronic recurrent multifocal osteomyelitis: drug reaction or cutaneous manifestation of the disease? A critical review on the topic with an emblematic case report

(2023) Maurizio Romagnuolo et al.   Frontiers in Medicine

Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments

(2022) Carlo Alberto Maronese et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Pyoderma Gangrenosum and Interleukin Inhibitors: A Semi-Systematic Review

(2021) Hakim Ben Abdallah et al.   DERMATOLOGY

Paradoxical Skin Reaction to Certolizumab, an Overlap of Pyoderma Gangrenosum and Psoriasis in a Young Woman Treated for Ankylosing Spondylitis: Case Report with Literature Review

(2020) Anna Gawdzik et al.   Dermatology and Therapy

Certolizumab for the treatment of localized pyoderma gangrenosum associated with Crohn's disease: A case report

(2020) Thomas Michael Pender et al.   Dermatologic Therapy

Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review

(2019) Hakim Ben Abdallah et al.   International Wound Journal

Neutrophilic dermatoses. Part II. Pyoderma gangrenosum and other bowel and arthritis associated neutrophilic dermatoses

(2018) Hovik J. Ashchyan et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Effective Strategies for the Management of Pyoderma Gangrenosum: A Comprehensive Review

(2015) F Patel et al.   ACTA DERMATO-VENEREOLOGICA

Pathophysiology of pyoderma gangrenosum (PG): An updated review

(2015) Sara F. Braswell et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial

(2015) A. D. Ormerod et al.   BMJ-British Medical Journal

Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial

(2015) A. D. Ormerod et al.   BMJ-British Medical Journal

Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients

(2011) A.M. Binus et al.   BRITISH JOURNAL OF DERMATOLOGY

Certolizumab Pegol

(2010) Niti Goel et al.   mAbs